NPPA issued a notification regarding the fixation of the retail price of Calcium IP eq. to Atorvastatin 40 mg (As green coloured spherical pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As two brown coloured film coated tablets Each containing 37.5 mg Clopidogrel Tablets IP) for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Corona Remedies Ltd. (Marketer)

Apr 14, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on April 13, 2026, issued a notification regarding the fixation of the retail price of Calcium IP eq. to Atorvastatin 40 mg (As green coloured spherical pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As two brown coloured film coated tablets Each containing 37.5 mg Clopidogrel Tablets IP) for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Corona Remedies Ltd. (Marketer).

It states that the price for each hard gelatin capsule containing: Calcium IP eq. to Atorvastatin 40 mg (As green coloured spherical pellets) + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As two brown coloured film coated tablets, each containing 37.5 mg Clopidogrel Tablets IP) has been fixed at Rs. 30.48/- excluding GST.

[Notification no. - 19(5100)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT